TriloTalk episode 37 focuses on a specific type of medical device, the drug-delivery system. Writing for drug-delivery systems is all about being fluent in two languages – drugs and devices. Julia Forjanic Klapproth, Senior Partner at Trilogy, Laura Collada, Senior Medical Writing Manager at Trilogy, and Raquel Billiones, Director of Medical Writing at AstraZeneca, talk about this and what medical writers need to understand when crafting these regulatory documents.
All content for TriloTalk is the property of Trilogy Writing & Consulting and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
TriloTalk episode 37 focuses on a specific type of medical device, the drug-delivery system. Writing for drug-delivery systems is all about being fluent in two languages – drugs and devices. Julia Forjanic Klapproth, Senior Partner at Trilogy, Laura Collada, Senior Medical Writing Manager at Trilogy, and Raquel Billiones, Director of Medical Writing at AstraZeneca, talk about this and what medical writers need to understand when crafting these regulatory documents.
Episode 18: Clinical Study Protocol Development from a Writer's Perspective
TriloTalk
34 minutes
2 years ago
Episode 18: Clinical Study Protocol Development from a Writer's Perspective
Join Julia and Jonathan for the 2nd part of a discussion dedicated to the development of Clinical Study Protocols, as they delve into the intricacies of writing these crucial documents. In this discussion, they explore the level of involvement a writer should have to ensure a well-written protocol. Tune in to gain valuable insights and guidance on creating effective protocols that drive successful clinical studies.
TriloTalk
TriloTalk episode 37 focuses on a specific type of medical device, the drug-delivery system. Writing for drug-delivery systems is all about being fluent in two languages – drugs and devices. Julia Forjanic Klapproth, Senior Partner at Trilogy, Laura Collada, Senior Medical Writing Manager at Trilogy, and Raquel Billiones, Director of Medical Writing at AstraZeneca, talk about this and what medical writers need to understand when crafting these regulatory documents.
